EPA-1549 - A randomized, active-controlled rater-blinded 2-year study of paliperidone palmitate versus investigators’ choice of oral antipsychotic monotherapy in patients with schizophrenia (prosipal)
Autor: | Schreiner, A., Aadamsoo, K., Altamura, A.C., Franco, M., Goorwood, P., Neznanov, N.G., Schronen, J., Ucok, A., Zink, M., Cherubin, P., Lahaye, M., Hargarter, L. |
---|---|
Zdroj: | In European Psychiatry 2014 29 Supplement 1:1-1 |
Databáze: | ScienceDirect |
Externí odkaz: |